Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Zwimpfer TA, Fereday S, Pandey A, Ariyaratne D, Jayawardana MW, Twomey L, Laumont CM, Kennedy CJ, Bolithon A, Meagher NS, Milne K, Hamilton P, Alsop J, Antoniou AC, Au-Yeung G, Beckmann MW, Berrington de Gonzalez A, Bisinotto C, Blome F, Bodelon C, Boros J, Brand AH, Carney ME, Cazorla-Jiménez A, Chiu DS, Christie EL, Chudecka-Głaz A, Coulson P, Cushing-Haugen KL, Cybulski C, Darcy KM, David C, Davidson T, Ekici AB, Elishaev E, Emons J, Engler T, Farrell R, Fischer A, García-Closas M, Gentry-Maharaj A, Ghatage P, Glasspool R, Harter P, Hartkopf AD, Hartmann A, Heikaus S, Hernandez BY, Hettiaratchi A, Heublein S, Huntsman DG, Jimenez-Linan M, Jones ME, Kang E, Kaznowska E, Kluz T, Kommoss FKF, Konecny G, Kruitwagen RFPM, Kwon J, Lambrechts D, Lee CH, Lester J, Leung SCY, Leung Y, Linder A, Lissowska J, Loverix L, Lubiński J, Mateoiu C, McNeish IA, Moubarak M, Nelson GS, Nevins N, Olawaiye AB, Olbrecht S, Orsulic S, Osorio A, Quinn CM, Mohan GR, Ray-Coquard I, Rodríguez-Antona C, Roxburgh P, Ruebner M, Salfinger SG, Samra S, Schoemaker MJ, Sinn HP, Sonke GS, Steele L, Stewart CJR, Talhouk A, Tan A, Tarney CM, Taylor SE, Van de Vijver KK, van der Aa MA, Van Gorp T, Van Nieuwenhuysen E, Van-Wagensveld L, Wahner-Hendrickson AE, Walter C, Wang C, Welz J, Wentzensen N, Wilkens LR, Winham SJ, Winterhoff B, Anglesio MS, Berchuck A, Candido Dos Reis FJ, Cohen PA, Conrads TP, Crowe P, Doherty JA, Fasching PA, Fortner RT, García MJ, Gayther SA, Goodman MT, Gronwald J, Harris HR, Heitz F, Horlings HM, Karlan BY, Kelemen LE, Larry Maxwell G, Menon U, Modugno F, Neuhausen SL, Schildkraut JM, Staebler A, Sundfeldt K, Swerdlow AJ, Vergote I, Wu AH, Brenton JD, Pharoah PDP, Pearce CL, Pike MC, Goode EL, Ramus SJ, Köbel M, Nelson BH, DeFazio A, Friedlander ML, Bowtell DDL, Garsed DW

Open source

DOI
10.1038/s41467-026-71134-3
Published
2026 Apr 1
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-71134-3,
  title = {Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.},
  author = {Zwimpfer TA and Fereday S and Pandey A and Ariyaratne D and Jayawardana MW and Twomey L and Laumont CM and Kennedy CJ and Bolithon A and Meagher NS and Milne K and Hamilton P and Alsop J and Antoniou AC and Au-Yeung G and Beckmann MW and Berrington de Gonzalez A and Bisinotto C and Blome F and Bodelon C and Boros J and Brand AH and Carney ME and Cazorla-Jiménez A and Chiu DS and Christie EL and Chudecka-Głaz A and Coulson P and Cushing-Haugen KL and Cybulski C and Darcy KM and David C and Davidson T and Ekici AB and Elishaev E and Emons J and Engler T and Farrell R and Fischer A and García-Closas M and Gentry-Maharaj A and Ghatage P and Glasspool R and Harter P and Hartkopf AD and Hartmann A and Heikaus S and Hernandez BY and Hettiaratchi A and Heublein S and Huntsman DG and Jimenez-Linan M and Jones ME and Kang E and Kaznowska E and Kluz T and Kommoss FKF and Konecny G and Kruitwagen RFPM and Kwon J and Lambrechts D and Lee CH and Lester J and Leung SCY and Leung Y and Linder A and Lissowska J and Loverix L and Lubiński J and Mateoiu C and McNeish IA and Moubarak M and Nelson GS and Nevins N and Olawaiye AB and Olbrecht S and Orsulic S and Osorio A and Quinn CM and Mohan GR and Ray-Coquard I and Rodríguez-Antona C and Roxburgh P and Ruebner M and Salfinger SG and Samra S and Schoemaker MJ and Sinn HP and Sonke GS and Steele L and Stewart CJR and Talhouk A and Tan A and Tarney CM and Taylor SE and Van de Vijver KK and van der Aa MA and Van Gorp T and Van Nieuwenhuysen E and Van-Wagensveld L and Wahner-Hendrickson AE and Walter C and Wang C and Welz J and Wentzensen N and Wilkens LR and Winham SJ and Winterhoff B and Anglesio MS and Berchuck A and Candido Dos Reis FJ and Cohen PA and Conrads TP and Crowe P and Doherty JA and Fasching PA and Fortner RT and García MJ and Gayther SA and Goodman MT and Gronwald J and Harris HR and Heitz F and Horlings HM and Karlan BY and Kelemen LE and Larry Maxwell G and Menon U and Modugno F and Neuhausen SL and Schildkraut JM and Staebler A and Sundfeldt K and Swerdlow AJ and Vergote I and Wu AH and Brenton JD and Pharoah PDP and Pearce CL and Pike MC and Goode EL and Ramus SJ and Köbel M and Nelson BH and DeFazio A and Friedlander ML and Bowtell DDL and Garsed DW},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-71134-3},
  url = {https://doi.org/10.1038/s41467-026-71134-3}
}

RIS

TY  - JOUR
TI  - Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
AU  - Zwimpfer TA
AU  - Fereday S
AU  - Pandey A
AU  - Ariyaratne D
AU  - Jayawardana MW
AU  - Twomey L
AU  - Laumont CM
AU  - Kennedy CJ
AU  - Bolithon A
AU  - Meagher NS
AU  - Milne K
AU  - Hamilton P
AU  - Alsop J
AU  - Antoniou AC
AU  - Au-Yeung G
AU  - Beckmann MW
AU  - Berrington de Gonzalez A
AU  - Bisinotto C
AU  - Blome F
AU  - Bodelon C
AU  - Boros J
AU  - Brand AH
AU  - Carney ME
AU  - Cazorla-Jiménez A
AU  - Chiu DS
AU  - Christie EL
AU  - Chudecka-Głaz A
AU  - Coulson P
AU  - Cushing-Haugen KL
AU  - Cybulski C
AU  - Darcy KM
AU  - David C
AU  - Davidson T
AU  - Ekici AB
AU  - Elishaev E
AU  - Emons J
AU  - Engler T
AU  - Farrell R
AU  - Fischer A
AU  - García-Closas M
AU  - Gentry-Maharaj A
AU  - Ghatage P
AU  - Glasspool R
AU  - Harter P
AU  - Hartkopf AD
AU  - Hartmann A
AU  - Heikaus S
AU  - Hernandez BY
AU  - Hettiaratchi A
AU  - Heublein S
AU  - Huntsman DG
AU  - Jimenez-Linan M
AU  - Jones ME
AU  - Kang E
AU  - Kaznowska E
AU  - Kluz T
AU  - Kommoss FKF
AU  - Konecny G
AU  - Kruitwagen RFPM
AU  - Kwon J
AU  - Lambrechts D
AU  - Lee CH
AU  - Lester J
AU  - Leung SCY
AU  - Leung Y
AU  - Linder A
AU  - Lissowska J
AU  - Loverix L
AU  - Lubiński J
AU  - Mateoiu C
AU  - McNeish IA
AU  - Moubarak M
AU  - Nelson GS
AU  - Nevins N
AU  - Olawaiye AB
AU  - Olbrecht S
AU  - Orsulic S
AU  - Osorio A
AU  - Quinn CM
AU  - Mohan GR
AU  - Ray-Coquard I
AU  - Rodríguez-Antona C
AU  - Roxburgh P
AU  - Ruebner M
AU  - Salfinger SG
AU  - Samra S
AU  - Schoemaker MJ
AU  - Sinn HP
AU  - Sonke GS
AU  - Steele L
AU  - Stewart CJR
AU  - Talhouk A
AU  - Tan A
AU  - Tarney CM
AU  - Taylor SE
AU  - Van de Vijver KK
AU  - van der Aa MA
AU  - Van Gorp T
AU  - Van Nieuwenhuysen E
AU  - Van-Wagensveld L
AU  - Wahner-Hendrickson AE
AU  - Walter C
AU  - Wang C
AU  - Welz J
AU  - Wentzensen N
AU  - Wilkens LR
AU  - Winham SJ
AU  - Winterhoff B
AU  - Anglesio MS
AU  - Berchuck A
AU  - Candido Dos Reis FJ
AU  - Cohen PA
AU  - Conrads TP
AU  - Crowe P
AU  - Doherty JA
AU  - Fasching PA
AU  - Fortner RT
AU  - García MJ
AU  - Gayther SA
AU  - Goodman MT
AU  - Gronwald J
AU  - Harris HR
AU  - Heitz F
AU  - Horlings HM
AU  - Karlan BY
AU  - Kelemen LE
AU  - Larry Maxwell G
AU  - Menon U
AU  - Modugno F
AU  - Neuhausen SL
AU  - Schildkraut JM
AU  - Staebler A
AU  - Sundfeldt K
AU  - Swerdlow AJ
AU  - Vergote I
AU  - Wu AH
AU  - Brenton JD
AU  - Pharoah PDP
AU  - Pearce CL
AU  - Pike MC
AU  - Goode EL
AU  - Ramus SJ
AU  - Köbel M
AU  - Nelson BH
AU  - DeFazio A
AU  - Friedlander ML
AU  - Bowtell DDL
AU  - Garsed DW
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-71134-3
UR  - https://doi.org/10.1038/s41467-026-71134-3
ER  -

APA

TA, Z., S, F., A, P., D, A., MW, J., L, T., CM, L., CJ, K., A, B., NS, M., K, M., P, H., J, A., AC, A., G, A., MW, B., A, B. D. G., C, B., F, B., C, B., J, B., AH, B., ME, C., A, C., DS, C., EL, C., A, C., P, C., KL, C., C, C., KM, D., C, D., T, D., AB, E., E, E., J, E., T, E., R, F., A, F., M, G., A, G., P, G., R, G., P, H., AD, H., A, H., S, H., BY, H., A, H., S, H., DG, H., M, J., ME, J., E, K., E, K., T, K., FKF, K., G, K., RFPM, K., J, K., D, L., CH, L., J, L., SCY, L., Y, L., A, L., J, L., L, L., J, L., C, M., IA, M., M, M., GS, N., N, N., AB, O., S, O., S, O., A, O., CM, Q., GR, M., I, R., C, R., P, R., M, R., SG, S., S, S., MJ, S., HP, S., GS, S., L, S., CJR, S., A, T., A, T., CM, T., SE, T., KK, V. D. V., MA, V. D. A., T, V. G., E, V. N., L, V., AE, W., C, W., C, W., J, W., N, W., LR, W., SJ, W., B, W., MS, A., A, B., FJ, C. D. R., PA, C., TP, C., P, C., JA, D., PA, F., RT, F., MJ, G., SA, G., MT, G., J, G., HR, H., F, H., HM, H., BY, K., LE, K., G, L. M., U, M., F, M., SL, N., JM, S., A, S., K, S., AJ, S., I, V., AH, W., JD, B., PDP, P., CL, P., MC, P., EL, G., SJ, R., M, K., BH, N., A, D., ML, F., DDL, B., & DW, G. (2026). Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.. Nature communications. https://doi.org/10.1038/s41467-026-71134-3

Source records